James M Roth sold $62k of GTM
Chief Revenue Officer at ZoomInfo Technologies Inc.. 20,774 shares at an average of $2.98, traded Jul 2, 2026, filed Jul 6, 2026.
Score components
- +15RoleOfficer
- +7Trade size$62k at market
- 0Share of holdings soldSold 9.2% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002057761-26-000014, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | MOption exercise Common Stock10b5-1 | +4,465 | - | - | 144,460 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Common Stock10b5-1 | +30,638 | - | - | 175,098 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Common Stock10b5-1 | +22,059 | - | - | 197,157 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Common Stock10b5-1 | +18,522 | - | - | 215,679 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Common Stock10b5-1 | +80,937 | - | - | 296,616 | Jul 6, 2026 |
| Jul 1, 2026 | FTax withholding Common Stock10b5-1 | -70,638 | $2.93 | $207k | 225,978 | Jul 6, 2026 |
| Jul 2, 2026 | SOpen-market sale Common Stock10b5-1 | -20,774 | $2.98 | $62k | 205,204 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -4,465 | $0.00 | $0 | 13,393 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -30,638 | $0.00 | $0 | 30,639 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -22,059 | $0.00 | $0 | 66,176 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -18,522 | $0.00 | $0 | 129,652 | Jul 6, 2026 |
| Jul 1, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -80,937 | $0.00 | $0 | 566,563 | Jul 6, 2026 |
Related signals
Other insiders at ZoomInfo Technologies Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| Pro nowfree Oct 20, 2026 | ZoomInfo Technologies Inc. | Michael Graham O'Brien CFO | $20k 5,000 shares | -1% | |
| 0Weak | ZoomInfo Technologies Inc. | Ashley McGrane General Counsel and Corp Sec | $9,239 2,461 shares | -2% | |
| 3Weak | ZoomInfo Technologies Inc. | James M Roth Chief Revenue Officer | $77k 20,773 shares | -7% | |
| 0Weak | ZoomInfo Technologies Inc. | Ashley McGrane General Counsel and Corp Sec | $142 34 shares | -0% | |
| 0Weak | ZoomInfo Technologies Inc. | James M Roth Chief Revenue Officer | $392 94 shares | -0% | |
| 36Weak | ZoomInfo Technologies Inc. | Ashley McGrane General Counsel and Corp Sec | $68k 16,400 shares | -13% | |
| 10Weak | ZoomInfo Technologies Inc. | Michael Graham O'Brien CFO | $20k 5,000 shares | -2% | |
| 0Weak | ZoomInfo Technologies Inc. | Ashley McGrane General Counsel and Corp Sec | $3,553 997 shares | -1% | |
| 0Weak | ZoomInfo Technologies Inc. | Ashley McGrane General Counsel and Corp Sec | $7,331 2,461 shares | -2% | |
| 0Weak | ZoomInfo Technologies Inc. | Ashley McGrane General Counsel and Corp Sec | $121 34 shares | -0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.